ILIM
ARRY

Irish Life Investment Managers’s Array Biopharma Inc ARRY Stock Holding History

Irish Life Investment Managers’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$45.2K Buy
+10,000
New +$53.8K ﹤0.01% 1474

Other funds holding ARRY

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Irish Life Investment Managers's ARRY Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Array Biopharma Inc (ARRY) in Q2 2013: 10,000 shares worth $45.2K. The stake represents ﹤0.01% of the portfolio and ranks #1474 among its holdings.

128 funds tracked by Wall St. Rank hold ARRY as of Q2 2013.

  • Irish Life Investment Managers held 10,000 shares of Array Biopharma Inc worth $45.2K as of Q2 2013.
  • Array Biopharma Inc was a new Irish Life Investment Managers position in Q2 2013.
  • Array Biopharma Inc made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1474 holding.
  • 128 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.